Jinyu bio-technology: The industry is in the lowest point in history. New products next year will contribute to revenue growth | Direct coverage of the earnings conference.

① At the performance briefing, the chairman of jinyu bio-technology, Zhang Chongyu, admitted that the industry is currently at its lowest point in history; ② The company stated that competition in the pig vaccine market is fierce, and it will maintain its existing market share. Several new vaccines will be launched in the next two years, and it is expected that the new products will contribute a certain revenue increment next year.

cls.cnNov 28 05:50 ET

Jinyu Bio-technology's (SHSE:600201) Soft Earnings Are Actually Better Than They Appear

Simply Wall StNov 6 17:40 ET

jinyu bio-technology (600201.SH): No share repurchase for now

Gelonghui November 4th | Jinyu bio-technology (600201.SH) announced that as of October 31, 2024, the company has not repurchased shares yet. The company will implement the repurchase plan at an opportune time according to market conditions.

Gelonghui FinanceNov 4 04:32 ET

Estimating The Fair Value Of Jinyu Bio-technology Co., Ltd. (SHSE:600201)

Simply Wall StNov 4 01:59 ET

Jinyu Bio-technology Obtains Drug Registration Certificate for Bovine Brucellosis Vaccine

MT NewswiresNov 1 03:31 ET

Jinyu bio-technology (600201.SH): Subsidiary obtains new veterinary drug registration certificate

Jinyu Bio-Technology (600201.SH) announced on October 31st that, in accordance with the national "Veterinary Drug Administration Regulations" and "Veterinary Drug Registration Measures", after review by the Ministry of Agriculture and Rural Affairs, the fully-owned subsidiary of Jinyu Bio-Technology, Jinyu Baoling Biopharmaceutical Co., Ltd. (referred to as "Jinyu Baoling"), was approved to participate in the research and development of the Brucellosis live vaccine (S19 strain), which is a new veterinary drug. The company was issued the "New Veterinary Drug Registration Certificate". Brucellosis is a zoonotic infectious disease caused by Brucella. In order to effectively prevent and control bovine brucellosis, the company collaborated with the United States Department of Agriculture's Animal and Plant Health Inspection Service and the National Veterinary Bureau.

Gelonghui FinanceOct 31 04:36 ET